KR850002095A - 4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법 - Google Patents

4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR850002095A
KR850002095A KR1019840005440A KR840005440A KR850002095A KR 850002095 A KR850002095 A KR 850002095A KR 1019840005440 A KR1019840005440 A KR 1019840005440A KR 840005440 A KR840005440 A KR 840005440A KR 850002095 A KR850002095 A KR 850002095A
Authority
KR
South Korea
Prior art keywords
alkyl
dihydropyrazolo
preparing
pyridine derivative
formula
Prior art date
Application number
KR1019840005440A
Other languages
English (en)
Other versions
KR910002838B1 (ko
Inventor
이꾸오 아다찌 (외 3)
Original Assignee
요시또시 가즈오
시오노기 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시또시 가즈오, 시오노기 세이야꾸 가부시끼 가이샤 filed Critical 요시또시 가즈오
Publication of KR850002095A publication Critical patent/KR850002095A/ko
Application granted granted Critical
Publication of KR910002838B1 publication Critical patent/KR910002838B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 하기 일반식(Ⅱ)의 화합물을 하기 일반식(Ⅲ)의 화합물과 반응시킴을 특징으로 하는 일반식(Ⅰ)의 4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법.
    (상기 식중, R1은 C1~C4알킬이고, R2는 C1~C4알킬이며, R3는 C2~C6알케닐, C4~C6시클로알케닐, C4~C6시클로알킬, C1~C4알킬, C1~C4알콕시, C1~C4알킬, C4~C6시클로알킬옥시 C1~C4알킬, 옥소 또는 보호된 옥소를 함유하는 C5~C|6시클로알킬, 5 또는 6원 시클로알킬렌아미노 C1~C4알킬, C1~C4할로알킬, 아다만틸, 1-메틸피롤리디닐 또는 1,3-디티올란-2-일이다.)
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840005440A 1983-09-08 1984-09-05 4.7-디히드로피라졸로[3,4-b]피리딘 유도체의 제조방법 KR910002838B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP166258/1983 1983-09-08
JP166258 1983-09-08
JP58166258A JPS6056979A (ja) 1983-09-08 1983-09-08 ４，７−ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法

Publications (2)

Publication Number Publication Date
KR850002095A true KR850002095A (ko) 1985-05-06
KR910002838B1 KR910002838B1 (ko) 1991-05-06

Family

ID=15828039

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840005440A KR910002838B1 (ko) 1983-09-08 1984-09-05 4.7-디히드로피라졸로[3,4-b]피리딘 유도체의 제조방법

Country Status (7)

Country Link
US (1) US4562256A (ko)
JP (1) JPS6056979A (ko)
KR (1) KR910002838B1 (ko)
CH (1) CH661272A5 (ko)
DE (1) DE3432985A1 (ko)
FR (1) FR2551756B1 (ko)
GB (1) GB2146326B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873334A (en) * 1982-10-05 1989-10-10 Shionogi & Co., Ltd. 4,7-dihydropyrazolo(3,4-b) pyridine derivatives
JPS6210087A (ja) * 1985-07-03 1987-01-19 Shionogi & Co Ltd ４，７−ジヒドロチエノ〔２，３−ｂ〕ピリジン誘導体，その製造法および循環器系疾患治療剤
WO2002062795A2 (en) * 2001-02-02 2002-08-15 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857849A (en) * 1973-02-28 1974-12-31 Bayer Ag 2-amino-1,4-dihydropyridine derivatives
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd ４，７―ジヒドロピラゾロ［３，４―ｂ］ピリジン誘導体とその製造法
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
GR79111B (ko) * 1982-12-20 1984-10-02 Lepetit Spa

Also Published As

Publication number Publication date
FR2551756B1 (fr) 1987-10-02
DE3432985A1 (de) 1985-03-28
GB2146326A (en) 1985-04-17
GB2146326B (en) 1987-01-14
CH661272A5 (fr) 1987-07-15
GB8421763D0 (en) 1984-10-03
JPH0437833B2 (ko) 1992-06-22
US4562256A (en) 1985-12-31
DE3432985C2 (ko) 1993-09-16
JPS6056979A (ja) 1985-04-02
KR910002838B1 (ko) 1991-05-06
FR2551756A1 (fr) 1985-03-15

Similar Documents

Publication Publication Date Title
KR840004441A (ko) 포스포리피드 유도체의 제조방법
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
KR830007686A (ko) 세팔로 스포린 유도체의 제조방법
KR830006198A (ko) 시클로헥산 유도체의 제조방법
KR850002095A (ko) 4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법
KR840004104A (ko) 페닐 피페라진 유도체의 제조방법
KR870004027A (ko) 디하이드로리제르그산의 n-알킬화 방법
KR870002062A (ko) 2,3-디히드로-1h-인덴 유도체의 제조 방법
KR850004470A (ko) 유기 화합물의 제조방법
KR830006302A (ko) 신규 피리미딘 유도체의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR830004322A (ko) 항알러지 및 항궤양제 1-옥소-1H-티아졸로 [3,2-a]피리미딘-2-카복사미드와 그의 중간물질
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR840005441A (ko) 헥사히드로디옥소피리미딘류의 제조방법
KR850001742A (ko) 큐말산 에스테르의 제조방법
KR870008840A (ko) 1-스티렌술포닐-2-옥소-5-히드록시 피롤리딘 유도체의 제조방법
KR840004123A (ko) 포스포리피드 유도체의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR850006406A (ko) 4,7-디히드로피라졸[3,4-b] 피리딘 유도체의 제조방법
KR870011124A (ko) 푸란 유도체의 제조방법
KR850006394A (ko) 치환된 옥시란의 제조방법
KR840009113A (ko) 7α-메톡시세팔로스포린 유도체의 제조방법
KR850004583A (ko) 페닐아세트아닐리드 유도체의 제조방법
KR860001817A (ko) 페니실린 유도체의 제조방법
KR850005413A (ko) 아미노니트로피리딘의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19940125

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee